{
  "resourceType" : "ConceptMap",
  "id" : "ConceptMapCGMToOMOP",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Narrativa gerada: ConceptMap ConceptMapCGMToOMOP</b></p><a name=\"ConceptMapCGMToOMOP\"> </a><a name=\"hcConceptMapCGMToOMOP\"> </a><p>Mapeamento de (não especificado) para (não especificado)</p><br/><p><b>Grupo 1 </b>Mapeamento de <a href=\"http://terminology.hl7.org/6.5.0/CodeSystem-v3-loinc.html\">Logical Observation Identifiers, Names and Codes (LOINC)</a> to <a href=\"CodeSystem-omop-concepts-stub.html\">OHDSI OMOP CDM Concepts (External Reference)</a></p><table class=\"grid\"><tr><td><b>Código fonte</b></td><td><b>Relacionamento</b></td><td><b>Código de destino</b></td><td><b>Comentário</b></td></tr><tr><td>2345-7 (Glucose [Mass/volume] in Serum or Plasma)</td><td><a href=\"http://hl7.org/fhir/R5/codesystem-concept-map-relationship.html#equivalent\" title=\"equivalent\">is equivalent to</a></td><td>3004501 (Glucose [Mass/volume] in Serum or Plasma)</td><td>VERIFIED OMOP mapping for blood glucose.\n- OMOP concept_id: 3004501\n- Domain: Measurement\n- Use for CGM readings with measurement_type_concept_id = 44818707\n- Unit_concept_id: 8840 (mg/dL) or 8753 (mmol/L)</td></tr><tr><td>97507-8 (Glucose management indicator)</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">GMI (formerly eA1C) estimates HbA1c from CGM data.\nFormula: GMI (%) = 3.31 + 0.02392 × [mean glucose in mg/dL]\nClinical significance: Allows real-time A1c estimation without blood draw.\nGAP: No OMOP concept exists for GMI.</td></tr><tr><td>41653-7 (Glucose [Mass/volume] mean in Serum or Plasma)</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">Mean glucose over CGM recording period. Use measurement_source_value for context.</td></tr></table><hr/><p><b>Grupo 2 </b>Mapeamento de <a href=\"CodeSystem-cgm-metrics-cs.html\">CGM Metrics CodeSystem</a> to <a href=\"CodeSystem-omop-concepts-stub.html\">OHDSI OMOP CDM Concepts (External Reference)</a></p><table class=\"grid\"><tr><td><b>Código fonte</b></td><td><b>Relacionamento</b></td><td><b>Código de destino</b></td><td><b>Comentário</b></td></tr><tr><td>tir (Time in Range (70-180 mg/dL))</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">CRITICAL GAP: TIR (Time in Range) has NO OMOP concept.\n- Target: &gt;70% per International Consensus 2019\n- Unit: percentage (%)\n- Most important CGM metric for clinical outcomes\nWorkaround: Store in measurement_source_value = 'TIR:{value}%'</td></tr><tr><td>tbr-l1 (Time Below Range Level 1 (54-69 mg/dL))</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">Target: &lt;4% per International Consensus. Hypoglycemia Level 1.</td></tr><tr><td>tbr-l2 (Time Below Range Level 2 (&lt;54 mg/dL))</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">Target: &lt;1% per International Consensus. Clinically significant hypoglycemia.</td></tr><tr><td>tar-l1 (Time Above Range Level 1 (181-250 mg/dL))</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">Target: &lt;25% per International Consensus. Hyperglycemia Level 1.</td></tr><tr><td>tar-l2 (Time Above Range Level 2 (&gt;250 mg/dL))</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">Target: &lt;5% per International Consensus. Clinically significant hyperglycemia.</td></tr><tr><td>cv (Coefficient of Variation (%))</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">CV = (SD / Mean) × 100\nTarget: &lt;36% indicates stable glycemia (Monnier et al.)\nCritical for glycemic variability assessment.</td></tr><tr><td>sd (Standard Deviation)</td><td colspan=\"2\" style=\"background-color: #efefef\">(not mapped)</td><td style=\"background-color: #efefef\">Glucose standard deviation. Unit: mg/dL or mmol/L.</td></tr></table></div>"
  },
  "url" : "https://2rdoc.pt/ig/ios-lifestyle-medicine/ConceptMap/ConceptMapCGMToOMOP",
  "version" : "0.1.0",
  "name" : "ConceptMapCGMToOMOP",
  "title" : "CGM Metrics to OMOP CDM Mapping",
  "status" : "active",
  "experimental" : false,
  "date" : "2025-11-28",
  "publisher" : "Ricardo Lourenço dos Santos",
  "contact" : [{
    "name" : "Ricardo Lourenço dos Santos",
    "telecom" : [{
      "system" : "url",
      "value" : "https://linktr.ee/ricardolsantos"
    }]
  }],
  "description" : "Maps Continuous Glucose Monitoring (CGM) metrics to OMOP CDM concepts for federated analytics.\n\nInternational Consensus on Time in Range (Battelino et al., Diabetes Care 2019):\n- TIR (Time in Range 70-180 mg/dL): Target >70% for most patients\n- TBR-L1 (54-69 mg/dL): <4% target\n- TBR-L2 (<54 mg/dL): <1% target\n- TAR-L1 (181-250 mg/dL): <25% target\n- TAR-L2 (>250 mg/dL): <5% target\n- CV (Coefficient of Variation): <36% indicates stable glycemia\n\nTarget OMOP Table: MEASUREMENT\n- measurement_concept_id: mapped OMOP concept\n- value_as_number: CGM metric value\n- unit_concept_id: 8840 (mg/dL) or 8753 (mmol/L)\n- measurement_type_concept_id: 44818707 (Patient self-reported/device)\n\nSupported CGM Systems:\n- Dexcom G6/G7, Stelo (consumer)\n- Abbott Libre 2/3\n- Medtronic Guardian\n- Consumer metabolic monitors (Levels, January AI)",
  "jurisdiction" : [{
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "150",
      "display" : "Europe"
    }]
  },
  {
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "021",
      "display" : "Northern America a/"
    }]
  },
  {
    "coding" : [{
      "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
      "code" : "005",
      "display" : "South America"
    }]
  },
  {
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "PT",
      "display" : "Portugal"
    }]
  },
  {
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "US",
      "display" : "United States of America"
    }]
  },
  {
    "coding" : [{
      "system" : "urn:iso:std:iso:3166",
      "code" : "BR",
      "display" : "Brazil"
    }]
  }],
  "purpose" : "Enable ETL transformation of CGM data from FHIR to OMOP CDM for participation in OHDSI federated research networks, diabetes registries, and metabolic health research.",
  "group" : [{
    "source" : "http://loinc.org",
    "target" : "http://athena.ohdsi.org/search-terms/terms",
    "element" : [{
      "code" : "2345-7",
      "display" : "Glucose [Mass/volume] in Serum or Plasma",
      "target" : [{
        "code" : "3004501",
        "display" : "Glucose [Mass/volume] in Serum or Plasma",
        "equivalence" : "equivalent",
        "comment" : "VERIFIED OMOP mapping for blood glucose.\n- OMOP concept_id: 3004501\n- Domain: Measurement\n- Use for CGM readings with measurement_type_concept_id = 44818707\n- Unit_concept_id: 8840 (mg/dL) or 8753 (mmol/L)"
      }]
    },
    {
      "code" : "97507-8",
      "display" : "Glucose management indicator",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "GMI (formerly eA1C) estimates HbA1c from CGM data.\nFormula: GMI (%) = 3.31 + 0.02392 × [mean glucose in mg/dL]\nClinical significance: Allows real-time A1c estimation without blood draw.\nGAP: No OMOP concept exists for GMI."
      }]
    },
    {
      "code" : "41653-7",
      "display" : "Glucose [Mass/volume] mean in Serum or Plasma",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "Mean glucose over CGM recording period. Use measurement_source_value for context."
      }]
    }],
    "unmapped" : {
      "mode" : "fixed",
      "code" : "0",
      "display" : "No OMOP concept - requires custom vocabulary extension"
    }
  },
  {
    "source" : "https://2rdoc.pt/ig/ios-lifestyle-medicine/CodeSystem/cgm-metrics-cs",
    "target" : "http://athena.ohdsi.org/search-terms/terms",
    "element" : [{
      "code" : "tir",
      "display" : "Time in Range (70-180 mg/dL)",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "CRITICAL GAP: TIR (Time in Range) has NO OMOP concept.\n- Target: >70% per International Consensus 2019\n- Unit: percentage (%)\n- Most important CGM metric for clinical outcomes\nWorkaround: Store in measurement_source_value = 'TIR:{value}%'"
      }]
    },
    {
      "code" : "tbr-l1",
      "display" : "Time Below Range Level 1 (54-69 mg/dL)",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "Target: <4% per International Consensus. Hypoglycemia Level 1."
      }]
    },
    {
      "code" : "tbr-l2",
      "display" : "Time Below Range Level 2 (<54 mg/dL)",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "Target: <1% per International Consensus. Clinically significant hypoglycemia."
      }]
    },
    {
      "code" : "tar-l1",
      "display" : "Time Above Range Level 1 (181-250 mg/dL)",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "Target: <25% per International Consensus. Hyperglycemia Level 1."
      }]
    },
    {
      "code" : "tar-l2",
      "display" : "Time Above Range Level 2 (>250 mg/dL)",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "Target: <5% per International Consensus. Clinically significant hyperglycemia."
      }]
    },
    {
      "code" : "cv",
      "display" : "Coefficient of Variation (%)",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "CV = (SD / Mean) × 100\nTarget: <36% indicates stable glycemia (Monnier et al.)\nCritical for glycemic variability assessment."
      }]
    },
    {
      "code" : "sd",
      "display" : "Standard Deviation",
      "target" : [{
        "equivalence" : "unmatched",
        "comment" : "Glucose standard deviation. Unit: mg/dL or mmol/L."
      }]
    }],
    "unmapped" : {
      "mode" : "fixed",
      "code" : "0",
      "display" : "No OMOP concept - International Consensus 2019 metrics not yet in OMOP"
    }
  }]
}